Onward Medical N.V. (EBR:ONWD)
2.895
+0.005 (0.17%)
Sep 18, 2026, 5:37 PM CET
Onward Medical Revenue
Onward Medical had revenue of 4.19M EUR in the half year ending June 30, 2026, with 1,915.38% growth. This brings the company's revenue in the last twelve months to 8.42M, up 210.05% year-over-year. In the year 2025, Onward Medical had annual revenue of 5.41M with 211.33% growth.
Revenue (ttm)
8.42M
Revenue Growth
+210.05%
P/S Ratio
23.90
Revenue / Employee
61.47K
Employees
137
Market Cap
201.29M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.41M | 3.68M | 211.33% |
| Dec 31, 2024 | 1.74M | 1.21M | 226.88% |
| Dec 31, 2023 | 532.00K | -1.62M | -75.23% |
| Dec 31, 2022 | 2.15M | 749.00K | 53.54% |
| Dec 31, 2021 | 1.40M | 599.00K | 74.88% |
| Dec 31, 2020 | 800.00K | 246.00K | 44.40% |
| Dec 31, 2019 | 554.00K | 80.00K | 16.88% |
| Dec 31, 2018 | 474.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 8.52B |
| argenx SE | 4.65B |
| European Medical Solutions | 51.36M |
| Hyloris Pharmaceuticals | 7.94M |
| Oxurion NV | 555.00K |
| Celyad Oncology | 21.00K |
| Financière de Tubize | 13.26K |
| BioSenic | -2.39M |
Onward Medical News
- 11 days ago - Onward Medical Earnings Call Transcript: Q2 2026 - Transcripts
- 11 days ago - Onward Medical Earnings release: Q2 2026 - Filings
- 11 days ago - Onward Medical Quarterly report: Q2 2026 - Filings
- 11 days ago - Onward Medical Slides: Q2 2026 - Filings
- 11 days ago - ONWARD Medical Reports 250% Revenue Growth As ARC Therapy Pipeline Advances - Nasdaq
- 11 days ago - ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline - GlobeNewsWire
- 16 days ago - ONWARD Medical to Announce First-Half 2026 Results on September 9, 2026 - GlobeNewsWire
- 17 days ago - ONWARD Medical Marks First Implant In EIGER Study Of ARC-IM System - Nasdaq